[1]
L. G. Mantovani, “Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective”, FE, vol. 20, no. 1, Jul. 2019.